This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Omeros Corporation. Active years: 2017-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2018
Certainly! Here's the article about inventor Michael James McDermott:
Title: Pioneering Inventor Michael James McDermott: Revolutionizing Pharmaceutical Solutions in Clifton Park, NY
Introduction: Michael James McDermott's innovative spirit and dedication to creating solutions for complex challenges have solidified his reputation as a pioneering inventor in the Clifton Park, NY area and beyond.
Latest Patents: McDermott has two latest patents under his name. Firstly, "Solid state forms of a PDE10 inhibitor" which relates to a novel variable hydrate crystalline form of a specific compound, its preparation methods, pharmaceutical compositions, and use in PDE10 inhibition. Secondly, "Processes and intermediates for the preparation of a PDE10 inhibitor" that focuses on an improved process for preparing compounds useful in PDE10 inhibition, particularly emphasizing one specific compound's preparation.
Career Highlights: With a remarkable journey at Omeros Corporation, McDermott has showcased exceptional skills and expertise in the pharmaceutical industry. His relentless drive for innovation has propelled him towards pioneering advancements in pharmaceutical solutions.
Collaborations: McDermott's success is also attributed to his collaborative efforts with talented individuals at Omeros Corporation. Notable coworkers like Neil S Cutshall and Jennifer Lynn Gage have contributed to the success of his innovative projects.
Conclusion: In conclusion, Michael James McDermott's relentless pursuit of innovation and dedication to pharmaceutical advancements have positioned him as a trailblazer in the Clifton Park, NY area. His latest patents serve as a testament to his visionary approach in tackling complex challenges and creating groundbreaking solutions in the pharmaceutical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile